전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-3 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,016 programs
AntibodyLimited DatastaleGlaxoSmithKlinePhase 1

Cobolimab (Cobolimab)

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase1#monoclonal-antibody#GlaxoSmithKline
Trials 1Status Active
AntibodyLimited DatastaleChinese PLA General HospitalPhase 2

Colorectal cancer: Tunlametinib + cetuximab β (Colorectal cancer: Tunlametinib + cetuximab β)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#monoclonal-antibody#TreatmentforAdvancedPancreaticCa+1
Trials 1Status Recruiting
AntibodyLimited DatastaleMichael DonahoePhase 2

Combined Plasma Exchange (PEX, Combined Plasma Exchange, Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids)

IPF · IPF

#IPF#Antibody#Phase2#monoclonal-antibody#Michael
Trials 1Status Active
AntibodyLimited DatastaleMedical College of WisconsinPhase 1

atezolizumab (Tecentriq, Concurrent Atezolizumab)

Head and Neck Neoplasm · Head and Neck Neoplasm

#HeadandNeckNeoplasm#Antibody#Phase1#monoclonal-antibody#Medical
Trials 1Status Active
AntibodyLimited DatastaleCity of Hope Medical CenterPhase 1

pembrolizumab (Keytruda, Copper Cu 64-DOTA-pembrolizumab)

Metastatic Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm

#MetastaticMalignantSolidNeoplasm#Antibody#Phase1#monoclonal-antibody#City
Trials 1Status Discontinued
AntibodyLimited DatastaleRochePhase 2

Cryoablation Combined with Tirelizumab and Bevacizumab (Cryoablation Combined with Tirelizumab and Bevacizumab)

Metastatic Breast Cancer in the Liver · Metastatic Breast Cancer in the Liver

#MetastaticBreastCancerintheLiver#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Active
CGTLimited DatastaleGreat Ormond Street Hospital fo…Phase 1

BE752TBTTBCAR33PBL (Cryopreserved BE CAR33 T Cells, Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

Relapsed Acute Myeloid Leukaemia · Relapsed Acute Myeloid Leukaemia

#RelapsedAcuteMyeloidLeukaemia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
AntibodyLimited DatastaleMedical College of WisconsinPhase 3

Cyclophosphamide and Rituximab (Cyclophosphamide and Rituximab)

Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma · Recurrent Grade 1 Follicular Lymphoma

#RecurrentGrade1FollicularLymphom#Antibody#Phase3#monoclonal-antibody#RecurrentGrade2FollicularLymphom+1
Trials 1Status Discontinued
AntibodyLimited DatastaleScripps HealthPreclinical

Cyclophosphamide/Rituximab (Cyclophosphamide/Rituximab)

Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Relapsing-Remitting

#MultipleSclerosisRelapsing-Remit#Antibody#Preclinical#monoclonal-antibody#MultipleSclerosis+2
Trials 1Status Discontinued
CGTLimited DatastaleWashington University School of…Phase 2

Cytokine-induced memory-like NK cells (Cytokine-induced memory-like NK cells)

Refractory Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
AntibodyLimited DatastaleFudan UniversityPreclinical

DEBIRI Combined With Chemotherapy and Bevacizumab (DEBIRI Combined With Chemotherapy and Bevacizumab)

Colorectal Neoplasms · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Preclinical#monoclonal-antibody#Fudan
Trials 1Status Active
AntibodyLimited DatastaleJanssenPhase 1

Daratumumab and hyaluronidase-fihj (Darzalex Faspro, Darzalex Faspro (Daratumumab and hyaluronidase-fihj))

Hematologic Malignancy; Bone Marrow Transplant Rejection · Hematologic Malignancy

#HematologicMalignancy#Antibody#Phase1#monoclonal-antibody#BoneMarrowTransplantRejection+1
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenPhase 3

Daratumumab (Darzalex Faspro, Darzalex Faspro(Daratumumab))

Refractory or Relapsed Multiple Myeloma · FRα

#FR#Antibody#Phase3#monoclonal-antibody#RefractoryorRelapsedMultipleMyel+1
Trials 1Status Recruiting
AntibodyLimited DatastaleAssistance Publique - Hôpitaux …Phase 2

nivolumab (Opdivo, Decreasing starting times for beginning nivolumab, Time to Event Continual Reassessment Method (TITE-CRM, Decreasing starting times for beginning nivolumab (Time to Event Continual Reassessment Method (TITE-CRM) ))

B Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · B Acute Lymphoblastic Leukemia

#BAcuteLymphoblasticLeukemia#Antibody#Phase2#monoclonal-antibody#AcuteLymphoblasticLeukemia+2
Trials 1Status Recruiting
AntibodyLimited DatastaleCedars-Sinai Medical CenterPhase 1

Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab (Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab)

Glioblastoma; Glioblastoma Multiforme · Glioblastoma

#Glioblastoma#Antibody#Phase1#monoclonal-antibody#GlioblastomaMultiforme+1
Trials 1Status Active
CGTLimited DatastaleCartesian TherapeuticsPhase 1

Descartes-15 (Descartes-15)

Refractory Multiple Myeloma; Relapsed Multiple Myeloma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
AntibodyLimited DatastaleRoche Pharma AGPhase 2

Dinutuximab beta (Dinutuximab beta)

Neuroblastoma · Relapsed Neuroblastoma

#RelapsedNeuroblastoma#Antibody#Phase2#monoclonal-antibody#Neuroblastoma+1
Trials 1Status Active
AntibodyLimited DatastaleGlostrup University Hospital, C…Approved

etanercept or adalimumab (Discontinuation of TNF-alpha inhibitor and re-starting it if flare-up in disease activity, Discontinuation of TNF-alpha inhibitor and re-starting it if flare-up in disease activity (etanercept or adalimumab))

SPONDYLOARTHRITIS · SPONDYLOARTHRITIS

#SPONDYLOARTHRITIS#Antibody#Approved#monoclonal-antibody#Glostrup
Trials 1Status Discontinued
ADCLimited DatastaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin and Toripalimab)

Muscle Invasive Bladder Cancer; HER2 Expression · HER2

#HER2#ADC#Phase2#antibody-drug-conjugate#MuscleInvasiveBladderCancer+2
Trials 1Status Active
CGTLimited DatastaleBeijing GoBroad HospitalPhase 1

Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy (Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy)

B-cell Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting

31 / 51 pages

← PreviousNext →